Quebec leads the way as the first province to reimburse Luxturna® (voretigene neparvovec) for previously untreatable inherited retinal disease1 Approved by Health Canada in 2020, Luxturna® is a one-time gene therapy that… Read More
TORONTO, ON, October 17, 2022 – adMare BioInnovations (adMare) and Medicine by Design are pleased to announce their new memorandum of understanding (MOU) to support translation priorities, which will accelerate health innovation… Read More
The majority of Canada’s G20 peers have adopted a definition of a rare disease as one where fewer than 1 patient per 2,000 people are affected TORONTO, ON, October 17, 2022 – Today,… Read More
Michael Smith Health Research BC welcomes Dr. Ellie Griffith as the assistant vice-president, research programs, effective immediately. Working alongside the vice-president, research, Ellie will provide ongoing strategic leadership for the… Read More
BURNABY, BC – October 17, 2022 – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune… Read More
